Alexopoulos GS, Buckwalter K, Olin J, Martinez R, Wainscott C, Krishnan KR (2002). Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. Biological Psychiatry
Andreescu C, Lenze EJ, Dew MA, Begley AE, Mulsant BH, Dombrovski AY, Pollock BG, Stack J, Miller MD, Reynolds CF (2007). Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. British Journal of Psychiatry
Armstrong MJ, Gruber-Baldini AL, Reich SG, Fishman PS, Lachner C, Shulman LM (2014). Which features of Parkinson's disease predict earlier exit from the workforce?
Parkinsonism and Related Disorders
Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, Siderowf A, Schapira AH, Oertel W, Obeso JA, Olanow CW, Poewe W, Stern M (2013). Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. Lancet Neurology
Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2014). Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement Disorders
Brown RG, Landau S, Hindle JV, Playfer J, Samuel M, Wilson KC, Hurt CS, Anderson RJ, Carnell J, Dickinson L, Gibson G, van SR, Sellwood K, Thomas BA, Burn DJ (2011). Depression and anxiety related subtypes in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry
Burn DJ, Landau S, Hindle JV, Samuel M, Wilson KC, Hurt CS, Brown RG (2012). Parkinson's disease motor subtypes and mood. Movement Disorders
Chen JJ, Marsh L (2014). Anxiety in Parkinson's disease: identification and management. Therapeutic Advances in Neurological Disorders
Cohen A, Gilman SE, Houck PR, Szanto K, Reynolds CF III (2009). Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Social Psychiatry and Psychiatric Epidemiology
Collins LM, Lanza ST (2010). Latent Class and Latent Transition Analysis with Applications in the Social, Behavioral and Health Sciences. John Wiley & Sons, Inc.: Hoboken, NJ.
Copeland JR, Kelleher MJ, Kellett JM, Gourlay AJ, Gurland BJ, Fleiss JL, Sharpe L (1976). A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability. Psychological Medicine
Deane KH, Flaherty H, Daley DJ, Pascoe R, Penhale B, Clarke CE, Sackley C, Storey S (2014). Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease. BMJ Open
Dissanayaka NN, Sellbach A, Matheson S, O'Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD (2010). Anxiety disorders in Parkinson's disease: prevalence and risk factors. Movement Disorders
Dobkin RD, Menza M, Allen LA, Gara MA, Mark MH, Tiu J, Bienfait KL, Friedman J (2011). Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. American Journal of Psychiatry
Dobkin RD, Rubino JT, Friedman J, Allen LA, Gara MA, Menza M (2013). Barriers to mental health care utilization in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology
Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Coleman SY, Brooks DJ, Barker RA, Burn DJ (2014). Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. Movement Disorders
Evans D, Norman P (2009). Illness representations, coping and psychological adjustment to Parkinson's disease. Psychology and Health
Fahn S, Elton RL, members of the UPDRS development committee (1987). Unified Parkinson's Disease Rating Scale. In Recent Developments in Parkinson's Disease (ed. Fahn S., Marsden C. D. and Calne D. B.), pp. 153–164. Macmillan Health Care Information: Florham Park, NJ.
Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry
Gison A, Dall'Armi V, Donati V, Rizza F, Giaquinto S Irccs San Raffaele Pisana Rome Italy (2014). Dispositional optimism, depression, disability and quality of life in Parkinson's disease. Functional Neurology
Graham JW, Collins LM, Wugalter SE, Chung NK, Hansen WB (1991). Modeling transitions in latent stage-sequential processes: a substance use prevention example. Journal of Consulting and Clinical Psychology
Hamilton M (1960). A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry
Hoehn MM, Yahr MD (1967). Parkinsonism: onset progression and mortality. Neurology
Hughes TA, Ross HF, Mindham RH, Spokes EG (2004). Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurologica Scandinavica
Hurt CS, Burn DJ, Hindle J, Samuel M, Wilson K, Brown RG (2013). Thinking positively about chronic illness: an exploration of optimism, illness perceptions and well-being in patients with Parkinson's disease. British Journal of Health Psychology
Hurt CS, Landau S, Burn DJ, Hindle JV, Samuel M, Wilson K, Brown RG (2012). Cognition, coping, and outcome in Parkinson's disease. International Psychogeriatrics
Hurt CS, Thomas BA, Burn DJ, Hindle JV, Landau S, Samuel M, Wilson KC, Brown RG (2011). Coping in Parkinson's disease: an examination of the coping inventory for stressful situations. International Journal of Geriatric Psychiatry
Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I (1990). Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology
Lamers F, Rhebergen D, Merikangas KR, de JP, Beekman AT, Penninx BW (2012). Stability and transitions of depressive subtypes over a 2-year follow-up. Psychological Medicine
Lewis SJG, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005). Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. Journal of Neurology Neurosurgery and Psychiatry
Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, Bienfait K, Dicke A (2009). A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology
Menza MA, Robertson HD, Bonapace AS (1993). Parkinson's disease and anxiety: comorbidity with depression. Biological Psychiatry
Michl LC, McLaughlin KA, Shepherd K, Nolen-Hoeksema S (2013). Rumination as a mechanism linking stressful life events to symptoms of depression and anxiety: longitudinal evidence in early adolescents and adults. Journal of Abnormal Psychology
Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006). The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. International Journal of Geriatric Psychiatry
Moonen AJ, Wijers A, Leentjens AF, Christine CW, Factor SA, Juncos J, Lyness JM, Marsh L, Panisset M, Pfeiffer R, Rottenberg D, Serrano RC, Shulman L, Singer C, Slevin J, McDonald W, Auinger P, Richard IH (2014). Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. Parkinsonism and Related Disorders
Muthen LK, Muthen BO (2007). Mplus User's Guide. Muthen and Muthen: Los Angeles, CA.
Negre-Pages L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lepine JP, Rascol O (2010). Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study. Movement Disorders
Nuti A, Ceravolo R, Piccinni A, Dell'Agnello G, Bellini G, Gambaccini G, Rossi C, Logi C, Dell'Osso L, Bonuccelli U (2004). Psychiatric comorbidity in a population of Parkinson's disease patients. European Journal of Neurology
Office for National Statistics (2000). Standard Occupational Classification 2000. The Stationery Office: London.
Penninx BW, Nolen WA, Lamers F, Zitman FG, Smit JH, Spinhoven P, Cuijpers P, de Jong PJ, van Marwijk HW, van der Meer K, Verhaak P, Laurant MG, de GR, Hoogendijk WJ, van der Wee N, Ormel J, van DR, Beekman AT (2011). Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). Journal of Affective Disorders
Prentice R, Gloeckler L (1978). Regression analysis of grouped survival data with application to breast cancer data. Biometrics
Qureshi SU, Amspoker AB, Calleo JS, Kunik ME, Marsh L (2012). Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression. Journal of Geriatric Psychiatry and Neurology
Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG (2008). A systematic review of prevalence studies of depression in Parkinson's disease. Movement Disorders
Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, Factor SA, Juncos J, Serrano RC, Brodsky M, Manning C, Marsh L, Shulman L, Fernandez HH, Black KJ, Panisset M, Christine CW, Jiang W, Singer C, Horn S, Pfeiffer R, Rottenberg D, Slevin J, Elmer L, Press D, Hyson HC, McDonald W (2012). A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology
Riedel O, Dodel R, Deuschl G, Klotsche J, Forstl H, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Wittchen HU (2012). Depression and care-dependency in Parkinson's disease: results from a nationwide study of 1449 outpatients. Parkinsonism and Related Disorders
Schrag A, Jahanshahi M, Quinn N (2000). What contributes to quality of life in patients with Parkinson's disease?
J. Neurol. Neurosurg. Psychiatry
Schwab RS, England AC (1969). Projection technique for evaluating surgery for Parkinson's disease. In Third Symposium on Parkinson's Disease (ed. Gillingham F. J. and Donaldson M. C.), pp. 152–157. E&S Livingstone: Edinburgh.
Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C (2011). The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Movement Disorders
26 (Suppl. 3), S42–S80.
Shulman LM, Taback RL, Rabinstein AA, Weiner WJ (2002). Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism and Related Disorders
Silverman MN, Deuster PA (2014). Biological mechanisms underlying the role of physical fitness in health and resilience. Interface Focus
Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG (1992). A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry
StataCorp LP (2009). Stata 11 Base Reference Manual. Stata Press: College Station, TX.
Tandberg E, Larsen JP, Aarsland D, Cummings JL (1996). The occurrence of depression in Parkinson's disease. A community-based study. Archives of Neurology
Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010). Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Movement Disorders
Vu TC, Nutt JG, Holford NH (2012). Progression of motor and nonmotor features of Parkinson's disease and their response to treatment. British Journal of Clinical Pharmacology
Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB (2003). Recognition and treatment of depression in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology
Weintraub D, Morales KH, Moberg PJ, Bilker WB, Balderston C, Duda JE, Katz IR, Stern MB (2005). Antidepressant studies in Parkinson's disease: a review and meta-analysis. Movement Disorders
Whitelaw NA, Liang J (1991). The structure of the OARS physical health measures. Medical Care
Zigmond AS, Snaith RP (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica